Literature DB >> 34484957

Intractable Tuberculous Meningitis With Paradoxical Reactions Treated by Anti-Tissue Necrosis Factor-α Therapy.

Keon-Woo Kim1, Hyo Jae Kim1, Hyun-Woo Kim1, Sung-Han Kim1, Sang Ahm Lee1, Yong Seo Koo1.   

Abstract

Entities:  

Year:  2021        PMID： 34484957      PMCID： PMC8382441          DOI： 10.1212/CPJ.0000000000000946

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

1.  A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis.

Authors:  Jaimes-Hernández Jorge; Cárdenas Graciela; Aranda-Pereira Pablo; Soto-Hernández José Luis
Journal:  J Clin Rheumatol       Date:  2012-06       Impact factor: 3.517

Review 2.  Paradoxical reaction in HIV negative tuberculous meningitis.

Authors:  Ravindra Kumar Garg; Hardeep Singh Malhotra; Neeraj Kumar
Journal:  J Neurol Sci       Date:  2014-03-19       Impact factor: 3.181

3.  Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes.

Authors:  Timothy K Blackmore; Laurens Manning; William J Taylor; Robert S Wallis
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

4.  Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis.

Authors:  Ho-Su Lee; Yumi Lee; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  J Infect Chemother       Date:  2011-11-02       Impact factor: 2.211

5.  Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Authors:  Jeffrey M Gelfand; Michael J Bradshaw; Barney J Stern; David B Clifford; Yunxia Wang; Tracey A Cho; Laura L Koth; Stephen L Hauser; Jason Dierkhising; NgocHanh Vu; Subramaniam Sriram; Harold Moses; Francesca Bagnato; Jeffrey A Kaufmann; Deidre J Ammah; Tsion H Yohannes; Mark J Hamblin; Nagagopal Venna; Ari J Green; Siddharama Pawate
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

6.  Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.

Authors:  Anurag Kumar Singh; Hardeep Singh Malhotra; Ravindra Kumar Garg; Amita Jain; Neeraj Kumar; Neera Kohli; Rajesh Verma; Praveen Kumar Sharma
Journal:  BMC Infect Dis       Date:  2016-06-21       Impact factor: 3.090

7.  Adalimumab for Corticosteroid and Infliximab-Resistant Immune Reconstitution Inflammatory Syndrome in the Setting of TB/HIV Coinfection.

Authors:  Nilar Lwin; Michael Boyle; Joshua S Davis
Journal:  Open Forum Infect Dis       Date:  2018-01-30       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.